HeartBeat.bio AG

HeartBeat.bio AG

Private
ViennaHealthcare & Life Scienceshttps://www.heartbeat.bio/

Last Round

VC Round

Nov 2, 2023

Total Funding Raised

$6M

Momentum Score

25 /100

Company Overview

HeartBeat.bio AG is a biotechnology company building a highly scalable human organoid and AI-supported drug discovery platform for heart disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service, Government Contracts

AI Layer

Application

Keywords

cardiac organoidsCardioidsdrug discovery platformheart disease modelinghigh-throughput screeningcardiac drug discoveryheart-on-a-chiphuman organoid modelsinduced pluripotent stem cellsiPSCsTechBiocardiotoxicity testingalternative to animal testing3D cell cultureAI-driven drug discoveryphenotypic screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HeartBeat.bio AG Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HeartBeat.bio AG Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 2, 2023
SeedMay 4, 2021

Key People

Founding team and executive leadership

Florian Fuchs

Chief Technology Officer

Executive Team

HeartBeat.bio AG Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 106% MoM, reaching 7.5K.

  • Dec 9, 2025

    Monthly visitors increased 794% MoM to 3.7K.

HeartBeat.bio AG Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HeartBeat.bio AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HeartBeat.bio AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range29
Year Founded2021
Last FundingNov 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.